Auro Laboratories Ltd Share Price Today, Live NSE/BSE Updates

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open-

High-

Low-

Prev. Close-

Avg. Traded Price-

Volume-

MARKET DEPTH

Total bid0.00

Total ask0.00

Orders	Qty	Bid

Ask	Qty	Orders

HIGH/LOW

52w

LOW/HIGH

₹281.10a day ago

₹295.40a day ago

LOWER/UPPER CIRCUITS

₹231.00

₹346.40

Auro Laboratories Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Interest Coverage Ratio,is 3.75, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Stock Price,rose 62.57% and outperformed its sector by 43.82% in the past year.

Promoter Share Holding,increased by 0.03% in the most recent quarter to 52.18%.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 22.07%

Net profit growth 5Y CAGR : 12.11%

Similar stocks

SUNPHARMA₹1,693.60-9.80 (0.58%)

DIVISLAB₹6,731.50-59.00 (0.87%)

CIPLA₹1,482.30-0.10 (0.01%)

TORNTPHARM₹3,521.40+16.80 (0.48%)

MANKIND₹2,652.30+13.00 (0.49%)

Auro Laboratories limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), Intermediates and Generic Formulations. The company was founded and incorporated in 1992 at Mumbai, with a manufacturing facility located at Tarapur. Since inception it has focused on providing quality pharmaceuticals while maintaining high manufacturing standards. The company’s primary focus has been on Anti-Diabetic Drugs, which is estimated to be one of the fastest growing therapeutic segments. Currently, it manufactures Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment.

Grow your wealth with more research recommendations

+91

To visit the old Ventura website, click here.

Ventura Wealth Clients Login here